Pharmaceutical Industry Reports Levodopa Market | Page 2

REPORT DESCRIPTION
Levodopa Market – Overview
Development of novel formulations and efficient drug delivery methods for levodopa are expected to drive
growth of the levodopa market. For instance, a clinical study for gastric retentive Accordion Pill, an immediate
drug release formulation by Intec Pharma Ltd., is ongoing in clinical phase III and is expected to complete in
September 2018. Accordion Pill is a Carbidopa/Levodopa (AP-CD/LD) combinational oral drug delivery system,
which is designed to improve the efficacy and safety of existing CD/LD drugs by utilizing an efficient gastric
retention and specific release mechanism.
Moreover, Impel NeuroPharma Inc. is conducting phase II clinical study for INP103, a drug-device combination
product containing a drug component, L-dopa, and device component I231 Precision Olfactory Delivery (POD)
device. The study is expected to complete in November 2018.
Furthermore, advancement in diagnosis of Parkinson's disease (PD) progression is expected to boost growth of
levodopa market. For instance, a clinical study conducted by Washington University School of Medicine, for
measuring PD progression both by using Magnetic Resonance Imaging (MRI) and by controlled dose of levodopa
for discovering suitable biomarker of PD is currently in clinical phase I and is expected to complete in February
2019.